Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G4 Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial
about
Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G4 Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial
description
scientific article published on 12 August 2019
@en
name
Axitinib in Combination With T ...... : An Open-Label Phase IB Trial
@en
type
label
Axitinib in Combination With T ...... : An Open-Label Phase IB Trial
@en
prefLabel
Axitinib in Combination With T ...... : An Open-Label Phase IB Trial
@en
P2093
P356
P1476
Axitinib in Combination With T ...... : An Open-Label Phase IB Trial
@en
P2093
Bixia Tang
Chuanliang Cui
Huaning Zhou
Keith T Flaherty
P304
P356
10.1200/JCO.19.00210
P50
P577
2019-08-12T00:00:00Z